Realist evaluation of the impact, viability and transferability of an alcohol harm reduction support programme based on mental health recovery: the Vitae study protocol

Judith Martin-Fernandez, Nolwenn Stevens, Sarah Moriceau, Fuschia Serre, Hélène Blanc, Emmanuelle Latourte, Marc Auriacombe, Linda Cambon, Judith Martin-Fernandez, Nolwenn Stevens, Sarah Moriceau, Fuschia Serre, Hélène Blanc, Emmanuelle Latourte, Marc Auriacombe, Linda Cambon

Abstract

Introduction: Addiction is considered a chronic disease associated with a high rate of relapse as a consequence of the addictive condition. Most of the current therapeutic work focuses on the notion of relapse prevention or avoidance and the control of its determinants. Since only a small portion of patients can access alcohol addiction treatment, it is crucial to find a way to offer new support towards safe consumptions, reductions or cessations. The harm reduction (HR) approach and mental health recovery perspective offers another way to support the patient with alcohol addiction. Vitae is a realist evaluation of the impact, viability and transferability of the IACA! programme, an HR programme based on the principle of psychosocial recovery for people with alcohol use disorders.

Methods and analysis: The Vitae study adheres to the theory-driven evaluation framework where the realist evaluation method and contribution analysis are used to explore the effects, mechanisms and influence of context on the outcomes and to develop and adjust an intervention theory. This study is a 12-month, multi-case, longitudinal descriptive pilot study using mixed methods. It is multi-centred, and carried out in 10 addiction treatment or prevention centres. In this study, outcomes are related to the evolution of alcohol use and the beneficiaries trajectory in terms of psychosocial recovery during these 12 months after the start of IACA!. The target number of participants are 100 beneficiaries and 23 professionals.

Ethics and dissemination: This research was approved by the Committee for the Protection of Persons Ouest V n°: 21/008-3HPS and was reported to the French National Agency for the Safety of Health Products. All participants will provide consent prior to participation. The results will be reported in international peer-reviewed journals and presented at scientific and public conferences.

Trial registration numbers: NCT04927455; ID-RCB2020-A03371-38.

Keywords: mental health; public health; substance misuse.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Management process implemented by Santé!.
Figure 2
Figure 2
Timeline of the Vitae project.

References

    1. Rehm J, Shield KD. Alcohol use and cancer in the European Union. Eur Addict Res 2021;27:1–8. 10.1159/000507017
    1. Organization WH . Global status report on alcohol and health 2018. 2019. World Health Organization, 2019.
    1. GBD 2017 Risk Factor Collaborators . Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet 2018;392:1923–94. 10.1016/S0140-6736(18)32225-6
    1. Rehm J, Shield KD, Gmel G, et al. . Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. Eur Neuropsychopharmacol 2013;23:89–97. 10.1016/j.euroneuro.2012.08.001
    1. Praud D, Rota M, Rehm J, et al. . Cancer incidence and mortality attributable to alcohol consumption. Int J Cancer 2016;138:1380–7. 10.1002/ijc.29890
    1. Shield KD, Marant Micallef C, Hill C, et al. . New cancer cases in France in 2015 attributable to different levels of alcohol consumption. Addiction 2018;113:247–56. 10.1111/add.14009
    1. Soerjomataram I, Shield K, Marant-Micallef C, et al. . Cancers related to lifestyle and environmental factors in France in 2015. Eur J Cancer 2018;105:103–13. 10.1016/j.ejca.2018.09.009
    1. Probst C, Kilian C, Sanchez S, et al. . The role of alcohol use and drinking patterns in socioeconomic inequalities in mortality: a systematic review. Lancet Public Health 2020;5:e324–32. 10.1016/S2468-2667(20)30052-9
    1. Casswell S, Thamarangsi T. Reducing harm from alcohol: call to action. Lancet 2009;373:2247–57. 10.1016/S0140-6736(09)60745-5
    1. Rehm J. The risks associated with alcohol use and alcoholism. Alcohol Res Health 2011;34:135–43.
    1. Rehm J, Mathers C, Popova S, et al. . Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. The Lancet 2009;373:2223–33. 10.1016/S0140-6736(09)60746-7
    1. McLellan AT, Lewis DC, O'Brien CP, et al. . Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000;284:1689–95. 10.1001/jama.284.13.1689
    1. Auriacombe M, Serre F, Denis C. Diagnosis of addictions. The routledge Handbook of the philosophy and science of addiction. Routledge, 2018: 132–44.
    1. Fatseas M, Auriacombe M. Principes de la thérapeutique et des prises en charge en addictologie. Abrégé d'addictologie. Paris, 2009: 62–8.
    1. National Institute on Drug Abuse . Principles of drug addiction treatment: a research-based guide. Report No.: 1437926762. Third Edition, 2018.
    1. Lenton S, Single E. The definition of harm reduction. Drug Alcohol Rev 1998;17:213–9. 10.1080/09595239800187011
    1. Ellison ML, Belanger LK, Niles BL, et al. . Explication and definition of mental health recovery: a systematic review. Adm Policy Ment Health 2018;45:91–102. 10.1007/s10488-016-0767-9
    1. Davidson L, Roe D. Recovery from versus recovery in serious mental illness: one strategy for lessening confusion plaguing recovery. J Ment Health 2007;16:459–70. 10.1080/09638230701482394
    1. Watson DP, Shuman V, Kowalsky J, et al. . Housing first and harm reduction: a rapid review and document analysis of the US and Canadian open-access literature. Harm Reduct J 2017;14:30. 10.1186/s12954-017-0158-x
    1. Thabane L, Cambon L, Potvin L, et al. . Population health intervention research: what is the place for pilot studies? Trials 2019;20:309. 10.1186/s13063-019-3422-4
    1. Wang S, Moss JR, Hiller JE. Applicability and transferability of interventions in evidence-based public health. Health Promot Int 2006;21:76–83. 10.1093/heapro/dai025
    1. Cambon L, Minary L, Ridde V, et al. . Transferability of interventions in health education: a review. BMC Public Health 2012;12:497. 10.1186/1471-2458-12-497
    1. Chen HT. The bottom-up approach to integrative validity: a new perspective for program evaluation. Eval Program Plann 2010;33:205–14. 10.1016/j.evalprogplan.2009.10.002
    1. Chen HT. Theory-driven evaluations. Newbury Park, CA: Sage Publications, 1990: 326.
    1. Stame N. Theory-Based evaluation and types of complexity. Evaluation 2004;10:58–76. 10.1177/1356389004043135
    1. Weiss CH. Theory-based evaluation: past, present, and future. New Dir Eval sept 1997;1997:41–55. 10.1002/ev.1086
    1. De Silva MJ, Breuer E, Lee L, et al. . Theory of change: a theory-driven approach to enhance the medical Research Council's framework for complex interventions. Trials 2014;15:267. 10.1186/1745-6215-15-267
    1. Mayne J. Contribution analysis: coming of age? Evaluation 2012;18:270–80. 10.1177/1356389012451663
    1. Mayne J. Addressing Attribution through contribution analysis: using performance measures Sensibly | better evaluation. The Canadian Journal of Program Evaluation 2001;16.
    1. Pawson R, Tilley N. Realistic evaluation. SAGE Publications, 1997: 260.
    1. Pawson R, Greenhalgh T, Harvey G, et al. . Realist review--a new method of systematic review designed for complex policy interventions. J Health Serv Res Policy 2005;10 Suppl 1:21–34. 10.1258/1355819054308530
    1. Blaise P, Marchal B, Lefèvre P. Au-del des méthodes expérimentales: l'approche réaliste en évaluation, 2010.
    1. Pawson R. Evidence based policy: a realist perspective. SAGE Publications Ltd, 2006.
    1. Hawe P, Shiell A, Riley T. Complex interventions: how "out of control" can a randomised controlled trial be? BMJ 2004;328:1561–3. 10.1136/bmj.328.7455.1561
    1. Hawe P, Shiell A, Riley T. Theorising interventions as events in systems. Am J Community Psychol 2009;43:267–76. 10.1007/s10464-009-9229-9
    1. Cambon L, Minary L, Ridde V, et al. . [A tool to facilitate transferability of health promotion interventions: ASTAIRE]. Sante Publique 2014;26:783–6.
    1. Schloemer T, Schröder-Bäck P. Criteria for evaluating transferability of health interventions: a systematic review and thematic synthesis. Implement Sci 2018;13:88. 10.1186/s13012-018-0751-8
    1. Lacouture A, Breton E, Guichard A, et al. . The concept of mechanism from a realist approach: a scoping review to facilitate its operationalization in public health program evaluation. Implement Sci 2015;10:153. 10.1186/s13012-015-0345-7
    1. Ridde V, Robert E, Guichard A. L'approche réaliste l'épreuve Du réel de l'évaluation des programmes. The Canadian Journal of Program Evaluation 2011;26:37.
    1. Cambon L, Terral P, Alla F. From intervention to interventional system: towards greater theorization in population health intervention research. BMC Public Health 2019;19:339. 10.1186/s12889-019-6663-y
    1. McLellan AT, Kushner H, Metzger D, et al. . The fifth edition of the addiction severity index. J Subst Abuse Treat 1992;9:199–213. 10.1016/0740-5472(92)90062-S
    1. Denis C, Fatséas M, Beltran V, et al. . Usefulness and validity of the modified addiction severity index: a focus on alcohol, drugs, tobacco, and gambling. Substance Abuse 2016;37:168–75. 10.1080/08897077.2015.1036334
    1. McLellan T, Carise D, Coyne TH. Addiction severity index. 5th edition, 2019.
    1. Has . AddictionSeverity Index - Adaptation française, 2019.
    1. Sheehan DV, Lecrubier Y. The Mini International Psychiatric Interview - Plus (MINI-Plus, 2004.
    1. Sheehan DV, Lecrubier Y, Sheehan KH, et al. . The Mini-International neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59 Suppl 20:22–33.
    1. Cacciola JS, Alterman AI, Lynch KG, et al. . Initial reliability and validity studies of the revised treatment services review (TSR-6). Drug Alcohol Depend 2008;92:37–47. 10.1016/j.drugalcdep.2007.06.004
    1. McLellan AT, Alterman AI, Cacciola J, et al. . A new measure of substance abuse treatment. initial studies of the treatment services review. J Nerv Ment Dis 1992;180:101–10. 10.1097/00005053-199202000-00007
    1. Rogers ES, Chamberlin J, Ellison ML. Measure empowerment among users of mental health services. Psychiatric services 1997;48:1042–7.
    1. Rogers ES, Ralph RO, Salzer MS. Validating the empowerment scale with a multisite sample of consumers of mental health services. Psychiatr Serv 2010;61:933–6. 10.1176/ps.2010.61.9.933
    1. Creswell J, Clarkv P. Designing and conducting mixed methods research. 2017. 3rd ed. SAGE Publications, 2017.
    1. Gorphe P, Jannin C. Regulatory aspects of prospective and retrospective clinical research in France in 2018. Eur Ann Otorhinolaryngol Head Neck Dis 2019;136:103–8. 10.1016/j.anorl.2019.02.004
    1. Cohen E, Feinn R, Arias A, et al. . Alcohol treatment utilization: findings from the National epidemiologic survey on alcohol and related conditions. Drug Alcohol Depend 2007;86:214–21. 10.1016/j.drugalcdep.2006.06.008
    1. Rehm J, Allamani A, Elekes Z, et al. . Alcohol dependence and treatment utilization in Europe - a representative cross-sectional study in primary care. BMC Fam Pract 2015;16:90. 10.1186/s12875-015-0308-8
    1. Lappan SN, Brown AW, Hendricks PS. Dropout rates of in-person psychosocial substance use disorder treatments: a systematic review and meta-analysis. Addiction 2020;115:201–17. 10.1111/add.14793
    1. Cunningham JA, Sobell LC, Sobell MB, et al. . Barriers to treatment: why alcohol and drug abusers delay or never seek treatment. Addict Behav 1993;18:347–53. 10.1016/0306-4603(93)90036-9
    1. Grant BF. Barriers to alcoholism treatment: reasons for not seeking treatment in a general population sample. J Stud Alcohol 1997;58:365–71. 10.15288/jsa.1997.58.365
    1. Denis C, Fatséas M, Beltran V, et al. . Validity of the self-reported drug use section of the addiction severity index and associated factors used under naturalistic conditions. Subst Use Misuse 2012;47:356–63. 10.3109/10826084.2011.640732

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅